Rethink Cognitive Care with Boston Cognitive™

Screen

Assessment

Care Plan

 Screen Assessment Care Plan Screen, Assessment,
 Care Plan

 Screen  Assessment   Care Plan

A Comprehensive Digital Platform to Screen, Measure, and Manage Cognitive Function

Better Care, Better Revenue

Your complete pathway to cognitive care excellence

Screen

Quickly screen patients for cognitive impairment symptoms in under 2 minutes using the Boston Cognitive Screen™

Measure

Digitally assess and objectively evaluate patients’ cognitive concerns with the Boston Cognitive Assessment™(BoCA™)

Manage

Develop personalized care plans for patients with cognitive impairment and their caregivers leveraging the Boston Cognitive Care Plan™

Our Digital Toolkit

Explore digital cognitive health solutions for early detection, assessment, and ongoing care management.

Boston Cognitive Screen™

The Boston Cognitive Screening Tool is designed to efficiently screen patients for cognitive impairment in under 2 minutes. This tool allows for in-clinic self-administration, making it a versatile choice for healthcare providers looking to integrate quick cognitive assessments into their practice.

Boston Cognitive Assessment™

The Boston Cognitive Assessment™(BoCA™) provides a comprehensive validated digital evaluation of patients’ cognitive concerns.

MMSE, Mini-Cog BoCA™
Brief, under 10 minutes
Cost Effective
Clinically Validated
Reimbursable
Self-administered by Patient
Longitudinal Results
Provides normal ranges for age & sex
Randomized to avoid learning effect
Evaluates 8 domains of cognitive function

Boston Cognitive Care Plan™

The Boston Cognitive Care Plan™ provides a personalized approach to managing cognitive impairment in patients and supporting their caregivers. This tool identifies cognitive, functional, and behavioral issues, saving time for healthcare providers while ensuring comprehensive care management.

Who We Serve

Our cognitive health solutions are designed to support a variety of stakeholders in the healthcare ecosystem, each with unique needs and goals.

Healthcare Providers

Healthcare providers need a cost-effective and efficient solution to evaluate cognitive function, whether for forensic assessments or establishing a baseline to monitor cognitive function longitudinally. This is especially important as the population ages and new treatments become available.

Value-Based Providers

If your organization is driven by improving quality of care, creating cost savings, improving patient satisfaction, and identifying unrealized HCC RAF, your organization will benefit significantly from our cognitive software solutions.

Health IT Vendors

In today’s competitive RPM, CCM, and EHR software market, having distinctive features is essential to stand out from competitors and provide added value to your customers.

Healthcare Payors

Your mission is to improve the quality of healthcare, create cost savings, increase patient satisfaction, and identify unrealized HCC RAF. Boston Cognitive can help you achieve all of these goals.

Medical Sales Consultants

Boston Cognitive offers the most-desired attributes medical sales consultants look 
for in a new product line. Reach out to learn how you can qualify to become a distributor!

Clinically Validated Results

Backed by Science

Boston cognitive assessment (BoCA) — a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance

Longitudinal cognitive testing is essential for developing novel preventive interventions for dementia and Alzheimer’s disease. The few available tools, such as MOCA, MMSE, and Mini-Cog, have significant practice effect and depend on an external evaluator. This study validates a self-administered 10-min at-home test intended for longitudinal cognitive monitoring, Boston Cognitive Assessment or BOCA

The Boston cognitive assessment: Psychometric foundations of a self-administered measure of global cognition

In this study the BoCA demonstrated good internal consistency (α = 0.79) and strong correlations (r = 0.80, p < 0.01) with the TICS; as well as a strong (r = 0.89, p < 0.001) test–retest reliability of the total BoCA score one week after participants’initial administration. BoCA was found it to possess equal or better sensitivity (79%) and specificity (90%) to mild cognitive impairment relative to other global screening tests.

Preliminary Analysis of the Influence of Age and Education on the Boston Cognitive Assessment (BoCA)

This study yielded a model with age being a significant predictor of total BoCA scores. Education did not contribute significantly

Preliminary Analysis of the Influence of Age and Education on the Boston Cognitive Assessment (BoCA)

This study yielded a model with age being a significant predictor of total BoCA scores. Education did not contribute significantly

The Boston cognitive assessment: Psychometric foundations of a self-administered measure of global cognition

In this study the BoCA demonstrated good internal consistency (α = 0.79) and strong correlations (r = 0.80, p < 0.01) with the TICS; as well as a strong (r = 0.89, p < 0.001) test–retest reliability of the total BoCA score one week after participants’initial administration. BoCA was found it to possess equal or better sensitivity (79%) and specificity (90%) to mild cognitive impairment relative to other global screening tests.

Boston cognitive assessment (BoCA) — a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance

Longitudinal cognitive testing is essential for developing novel preventive interventions for dementia and Alzheimer’s disease. The few available tools, such as MOCA, MMSE, and Mini-Cog, have significant practice effect and depend on an external evaluator. This study validates a self-administered 10-min at-home test intended for longitudinal cognitive monitoring, Boston Cognitive Assessment or BOCA

Footnotes

1 University of Michigan’s Natonal Poll on Healthy Aging (NPHA), 2023.

2 Alzheimer’s Dement. 2021;17:1231–1243.

3 Based upon current National Correct Coding Initiative (NCCI) edits. Please check with your local payor policy.

4 National Average Payment Amount

5  https://health.gov/healthypeople/objectives-and-data/browse-objectives/dementias/reduce-proportion-preventable-hospitalizations-older-adults-dementia-dia-02

6 Journal of Palliative Medicine Volume 21, Number 4, 2018

7  https://www.cms.gov/files/document/2024-announcement-pdf.pdf